1) Management very focused on delivering results. Confident, low key yet quietly bullish
2) No guidance provided for FY2020 but indicated this year will be an exciting year in terms of earnings due to persistent growth in orders on top of additional orders related to Covid-19.
3) Major client #1 Edward Lifesciences is Top 5 global player in Cardiovascular device market. Major client #2 Ambu is Top player in single-use devices.
4) Due to excellent track records and necessary FDA and EMA approvals, have gained additional clients over the past 2 years.
5) Expansion programme planned. New products to be launched in 2nd Half of the year and have already received orders for them.
6) Based on the products that are jointly developed, can comfortably see growth and visibility over the next 10 years.
Above only a summary and not financial advice.
Those who own Scomnet, you should know what to do. Those who do not own Scomnet, hopefully you know what to do.
Hi gemfinder, i am unable to copy and paste from the Edge’s digital page. Hopeful and gohku have summarised the content. In addition to that: - Demand from medical cables have been strong, order volumes doubled since outbreak. - Strong USD and low copper price will provide tailwind for increased profits. - Their cables are FDA approved which provide an edge against competitors.
The top 30 shareholders control most of the shares. Their balance float is extremely low. Based on last year’s annual report, just by holding 100k shares one will be in the top 10% of the shareholders. This might deter big funds coming in, but I’m happy to hold and monitor.
just wait...all healthcare stocks are dropping...only blue chips stocks gain...2 options for you: a) buy at lower price and average down....b) wait and make profits when it is up
Modera report positive data on early stage of finding covid vaccine. Scomnet is producing high technical medical devices used in icu., which are in high demand now. Scomnet's dip today is in response to the development of vaccine. The final effective n safe approve vaccine is still a long way to go. Somnet by studying its potential has long way to go. I hope my assumption is correct.
As l observed the real-time trading, there are big players collecting this stock. They are collecting as the stock swing up and towards the closing bell they would suppress its price. Correct me if. I am wrong.
i do agree that collection is indeed and has already happened for this stock. I have been observing for 3 consecutive days that while some are selling, many should be collecting. Scomnet's recent disposable bronchoscope which has full approval from US authorities will be the catalyst for their tremendous growth not only in terms of monetized financial quarters but also opens them up to many opportunities in the medical industry. Scomnet is a company not to be missed for mid to long term investments.
As for other holders of Scomnet, don't let figures from other counters affect you. Every counter has got it's own pace. Hold tight to this and watch it grow steadily as it should.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Gemstar
431 posts
Posted by Gemstar > 2020-05-12 10:35 | Report Abuse
Should be rm1 above